Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 686

1.

Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis.

Konikoff MR, Blanchard C, Kirby C, Buckmeier BK, Cohen MB, Heubi JE, Putnam PE, Rothenberg ME.

Clin Gastroenterol Hepatol. 2006 Nov;4(11):1328-36. Epub 2006 Oct 23.

PMID:
17059896
2.

Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease.

Bhattacharya B, Carlsten J, Sabo E, Kethu S, Meitner P, Tavares R, Jakate S, Mangray S, Aswad B, Resnick MB.

Hum Pathol. 2007 Dec;38(12):1744-53. Epub 2007 Sep 27.

PMID:
17900656
3.

Exploring potential noninvasive biomarkers in eosinophilic esophagitis in children.

Subbarao G, Rosenman MB, Ohnuki L, Georgelas A, Davis M, Fitzgerald JF, Molleston JP, Croffie JM, Pfefferkorn MD, Corkins MR, Lim JR, Steiner SJ, Schaefer E, Gleich GJ, Gupta SK.

J Pediatr Gastroenterol Nutr. 2011 Dec;53(6):651-8. doi: 10.1097/MPG.0b013e318228cee6.

PMID:
21694637
4.

Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis.

Bullock JZ, Villanueva JM, Blanchard C, Filipovich AH, Putnam PE, Collins MH, Risma KA, Akers RM, Kirby CL, Buckmeier BK, Assa'ad AH, Hogan SP, Rothenberg ME.

J Pediatr Gastroenterol Nutr. 2007 Jul;45(1):22-31.

PMID:
17592361
5.

Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis.

Lucendo AJ, De Rezende L, Comas C, Caballero T, Bellón T.

Am J Gastroenterol. 2008 Sep;103(9):2184-93. doi: 10.1111/j.1572-0241.2008.01937.x.

PMID:
18844613
6.

Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia.

Sridhara S, Ravi K, Smyrk TC, Kita H, Kephart GM, Weiler CR, Katzka DA.

Clin Gastroenterol Hepatol. 2012 Jul;10(7):735-41. doi: 10.1016/j.cgh.2012.01.008. Epub 2012 Jan 28.

PMID:
22289868
7.

Changes in serum eotaxin and eosinophil cationic protein levels, and eosinophil count during treatment of childhood asthma.

Chu YT, Chiang W, Wang TN, Hung CH, Jong YJ, Wu JR.

J Microbiol Immunol Infect. 2007 Apr;40(2):162-7.

PMID:
17446966
8.

Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity.

Kim CK, Callaway Z, Fletcher R, Koh YY.

J Asthma. 2010 Jun;47(5):568-73. doi: 10.3109/02770901003792833.

PMID:
20560830
9.

Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo.

Cottin V, Deviller P, Tardy F, Cordier JF.

J Allergy Clin Immunol. 1998 Jan;101(1 Pt 1):116-23.

PMID:
9449510
10.

Infiltrating eosinophils and eotaxin: their association with idiopathic eosinophilic esophagitis.

Fujiwara H, Morita A, Kobayashi H, Hamano K, Fujiwara Y, Hirai K, Yano M, Naka T, Saeki Y.

Ann Allergy Asthma Immunol. 2002 Oct;89(4):429-32.

PMID:
12392390
11.

Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.

Xu J, Jiang F, Nayeri F, Zetterström O.

Respir Med. 2007 Jul;101(7):1447-54. Epub 2007 Mar 26.

12.

Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma.

Kim KW, Lee KE, Kim ES, Song TW, Sohn MH, Kim KE.

Lung. 2007 Mar-Apr;185(2):97-103. Epub 2007 Mar 28.

PMID:
17393238
13.

Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis.

Kephart GM, Alexander JA, Arora AS, Romero Y, Smyrk TC, Talley NJ, Kita H.

Am J Gastroenterol. 2010 Feb;105(2):298-307. doi: 10.1038/ajg.2009.584. Epub 2009 Nov 3.

14.

Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity.

Polzer K, Karonitsch T, Neumann T, Eger G, Haberler C, Soleiman A, Hellmich B, Csernok E, Distler J, Manger B, Redlich K, Schett G, Zwerina J.

Rheumatology (Oxford). 2008 Jun;47(6):804-8. doi: 10.1093/rheumatology/ken033. Epub 2008 Apr 8.

PMID:
18397958
15.

Diagnostic criteria for eosinophilic esophagitis: a 5-year retrospective review in a pediatric population.

Lai AL, Girgis S, Liang Y, Carr S, Huynh HQ.

J Pediatr Gastroenterol Nutr. 2009 Jul;49(1):63-70. doi: 10.1097/MPG.0b013e318184c917.

PMID:
19465874
16.

Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils.

El-Shazly A, Masuyama K, Nakano K, Eura M, Samejima Y, Ishikawa T.

Int Arch Allergy Immunol. 1998 Sep;117 Suppl 1:55-8.

PMID:
9758899
17.

Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism.

Mishra A, Rothenberg ME.

Gastroenterology. 2003 Nov;125(5):1419-27.

PMID:
14598258
18.

Longitudinal Evaluation of Noninvasive Biomarkers for Eosinophilic Esophagitis.

Min SB, Nylund CM, Baker TP, Ally M, Reinhardt B, Chen YJ, Nazareno L, Moawad FJ.

J Clin Gastroenterol. 2017 Feb;51(2):127-135. doi: 10.1097/MCG.0000000000000621.

PMID:
27479142
19.

Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis.

Stein ML, Collins MH, Villanueva JM, Kushner JP, Putnam PE, Buckmeier BK, Filipovich AH, Assa'ad AH, Rothenberg ME.

J Allergy Clin Immunol. 2006 Dec;118(6):1312-9. Epub 2006 Nov 7.

PMID:
17157662
20.

Peripheral blood eosinophils and other non-invasive biomarkers can monitor treatment response in eosinophilic oesophagitis.

Schlag C, Miehlke S, Heiseke A, Brockow K, Krug A, von Arnim U, Straumann A, Vieth M, Bussmann C, Mueller R, Greinwald R, Bajbouj M.

Aliment Pharmacol Ther. 2015 Nov;42(9):1122-30. doi: 10.1111/apt.13386. Epub 2015 Aug 27.

Supplemental Content

Support Center